Found 5 matching trials
Pro-urokinase for Extended-Window Posterior Circulation Stroke
PHASE3This study aims to evaluate whether, in patients with imaging-confirmed acu...
Location
Department of Neurology, the First Affiliated Hospital of Zhengzhou University
Study of rhPro-UK in Patients With Acute Ischaemic Stroke in 4.5 Hours After Stroke Onset(PROST)
PHASE3This is a randomized, rt-PA controlled, open-label phase 3 clinical study t...
Location
Beijing Luhe Hospital,Capital Medical University
SuPAR in Adult Patients With Covid-19
N/AThe biomarker soluble urokinase plasminogen activator receptor (suPAR) is t...
Location
University Hospital of Larisa, Department of Anesthesiology
Thrombolysis With rhPro-UK in 4.5-6 Hours After Acute Ischemic Stroke in a Double-blinded,Controlled Trial
PHASE3This is a randomized,controlled, double-blinded, phase 3 clinical study to ...
Location
XuanWu Hospital, Capital Medical University
rhPro-UK in Acute Ischaemic Stroke Within 4.5 Hours of Stroke Onset Trial 2(PROST-2)
PHASE3Intravenous thrombolysis is the first-line therapy in patients with acute i...
Location
Xuancheng People's Hospital